zoledronic acid has been researched along with Maxillary Diseases in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (47.22) | 29.6817 |
2010's | 19 (52.78) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrenfeld, M; Otto, S; Probst, F; Troeltzsch, M | 1 |
Alves, FA; Carvalho, PA; Lopes, RN; Rabelo, GD; Rocha, AC | 1 |
Cardoso, CL; Cavenago, BC; Curi, MM; Curra, C; Ferreira, O; Matsumoto, MA; Santiago, JF; Santos, PL | 1 |
Gallego, L; Junquera, L | 1 |
Anderson, KC; Lerman, MA; Lyng, GD; Sonis, ST; Watkins, BA | 1 |
Kogan, R; Lehrer, S; Montazem, A; Pessin-Minsley, M; Pfail, J; Ramanathan, L; Stock, RG | 1 |
Grasko, JM; Herrmann, RP; Vasikaran, SD | 1 |
Oliver, RJ; Seehra, J; Sloan, P | 1 |
Fenner, M; Hinkmann, FM; Lell, MM; Neukam, FW; Nkenke, E; Stockmann, P; Vairaktaris, E | 1 |
Eufinger, H; Hoefert, S; Schmitz, I; Tannapfel, A | 1 |
Danés, CF; Domingo, JP; Puigoriol, EB; Tuneu, NC | 1 |
Bernardeschi, P; D'Alessandro, M; Del Conte, A; Fiorentini, G; La Ferla, F; Montagnani, F; Turrisi, G | 1 |
Biasotto, M; Cavalli, F; Chiandussi, S; Contardo, L; Di Lenarda, R; Dore, F; Giacca, M; Moimas, S; Pozzato, G; Zacchigna, S; Zanconati, F | 1 |
Friedland, B; Treister, NS; Woo, SB | 1 |
Antonini, F; Azambuja, FG; Parente, EV; Pereira, CC | 1 |
D'Atri, AM; Fenell, CE; Fernandez, SA; Hueni, S; Huja, SS; Mason, A; Mo, X | 1 |
Hollstein, S; Hölzle, F; Kriwalsky, MS; Kunkel, M; Maurer, P; Rashad, A; Sandulescu, T; Stricker, I | 1 |
Bhattacharyya, I; Bowers, LM; Cohen, DM; Fitzpatrick, SG; Green, JG; Hinkson, DW; Neuman, AN; Stavropoulos, MF | 1 |
Adamo, D; Aria, M; Fortuna, G; Leuci, S; Mignogna, MD; Orabona, GD; Pollio, A; Ruoppo, E | 1 |
Bissinger, O; Ehrenfeld, M; Kolk, A; Mast, G; Mücke, T; Otto, S; Pautke, C; Schreyer, C; Stürzenbaum, SR; Wolff, KD | 1 |
Azambuja, AA; Berti-Couto, SA; Cherubini, K; da Silva, VD; Figueiredo, MA; Salum, FG; Vasconcelos, AC | 1 |
Bruscino-Raiola, F; Hewson, I; Syme, D | 1 |
Arranz Caso, JA; Dominguez-Mompello, JL; Flores Ballester, E; López Pizarro, V; Ngo Pombe, S; Restoy Lozano, A | 1 |
Bagan, J; Bagan, L; Margaix, M; Sheth, CC; Soria, JM | 1 |
Melo, MD; Obeid, G | 1 |
Nelson, MV | 1 |
Guarino, MJ; Hill, CE; Patel, K | 1 |
Corradi, D; Manfredi, M; Meleti, M; Merigo, E; Vescovi, P | 1 |
Fietkau, R; Gundlach, KK; Lenz, JH; Mueller, PC; Schmidt, W; Steiner-Krammer, B | 1 |
Eufinger, H; Hoefert, S | 1 |
Bishop, PA; Hay, KD | 1 |
Acevedo, AC; Cavalcanti, MG; Figueiredo, PT; Guerra, EN; Leite, AF; Melo, NS; Paula, AP; Paula, LM | 1 |
Baumann, A; Czerny, C; Eisenmenger, G; Ewers, R; Hoffmann, M; Moser, D; Pietschmann, P; Wutzl, A | 1 |
Bonaninil, M; Corcione, L; Corradi, D; D'Aleo, P; Ferrari, S; Guidotti, R; Manfredi, M; Meleti, M; Merigo, E; Poli, T; Ripasarti, A; Sesenna, E; Vescovi, P; Zanzucchi, E | 1 |
Briones, DL; Ferres, AJ; Herbozo, PJ; Torrealba, RL | 1 |
Gueiros, LA; Leão, JC; Lopes, MA | 1 |
2 review(s) available for zoledronic acid and Maxillary Diseases
Article | Year |
---|---|
[Bisphosphonate related osteonecrosis of the jaw and infection with Actinomyces].
Topics: Actinomyces; Actinomycosis; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Combined Modality Therapy; Diphosphonates; Disease Susceptibility; Etidronic Acid; Female; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Models, Biological; Neoplasms; Osteitis; Osteoporosis; Retrospective Studies; Risedronic Acid; Zoledronic Acid | 2012 |
Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Male; Maxillary Diseases; Osteonecrosis; Zoledronic Acid | 2006 |
2 trial(s) available for zoledronic acid and Maxillary Diseases
Article | Year |
---|---|
Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.
Topics: Aged; Bone Density Conservation Agents; Bone Marrow; Contrast Media; Diphosphonates; Female; Follow-Up Studies; Gadolinium; Humans; Imidazoles; Jaw Diseases; Magnetic Resonance Imaging; Male; Mandibular Diseases; Maxillary Diseases; Organometallic Compounds; Osteolysis; Osteonecrosis; Pamidronate; Radiography, Panoramic; Tomography, X-Ray Computed; Zoledronic Acid | 2010 |
Multiple myeloma vs. breast cancer patients with bisphosphonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Follow-Up Studies; Forecasting; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Pain Measurement; Proportional Hazards Models; Prospective Studies; Remission Induction; Treatment Outcome; Wound Healing; Zoledronic Acid | 2012 |
32 other study(ies) available for zoledronic acid and Maxillary Diseases
Article | Year |
---|---|
Conservative management of medication-related osteonecrosis of the maxilla with an obturator prosthesis.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Debridement; Denture Bases; Denture Design; Denture, Partial, Removable; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Maxillary Diseases; Middle Aged; Oroantral Fistula; Palatal Obturators; Surgical Wound Dehiscence; Zoledronic Acid | 2015 |
Surgical Therapy for Bisphosphonate-Related Osteonecrosis of the Jaw: Six-Year Experience of a Single Institution.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cohort Studies; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Osteotomy; Retrospective Studies; Surgical Flaps; Surgical Wound Dehiscence; Treatment Outcome; Wound Healing; Zoledronic Acid | 2015 |
Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.
Topics: Administration, Intravenous; Alveolar Bone Loss; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Imidazoles; Incisor; Male; Maxillary Diseases; Models, Animal; Osteitis; Osteolysis; Rats, Wistar; Tooth Extraction; X-Ray Microtomography; Zoledronic Acid | 2016 |
Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents, Local; Bone Density Conservation Agents; Bone Neoplasms; Chlorhexidine; Debridement; Diphosphonates; Female; Humans; Hydrogen Peroxide; Imidazoles; Maxillary Diseases; Middle Aged; Mouthwashes; Multiple Myeloma; Oroantral Fistula; Osteonecrosis; Tooth Extraction; Zoledronic Acid | 2009 |
Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Topics: Animals; Apoptosis; Bone Density Conservation Agents; Bone Diseases, Metabolic; Dexamethasone; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Injections, Intravenous; Jaw Diseases; Mandibular Diseases; Maxillary Diseases; Oral Ulcer; Osteonecrosis; Prospective Studies; Rats; Rats, Sprague-Dawley; Zoledronic Acid | 2009 |
Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.
Topics: Alendronate; Biomarkers; Bone and Bones; Bone Density Conservation Agents; Collagen Type I; Cysteine Endopeptidases; Diphosphonates; Female; Humans; Imidazoles; Male; Mandibular Diseases; Matrix Metalloproteinase 2; Maxillary Diseases; Osteocalcin; Osteonecrosis; Parathyroid Hormone; Peptides; Vitamin D; Zoledronic Acid | 2009 |
Recurrent low-energy femoral shaft fractures and osteonecrosis of the jaw in a case of multiple myeloma treated with bisphosphonates.
Topics: Bone Density Conservation Agents; Cross Infection; Diphosphonates; Escherichia coli Infections; Fatal Outcome; Femoral Fractures; Fractures, Spontaneous; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Osteopetrosis; Recurrence; Zoledronic Acid | 2009 |
Paget's disease of bone and osteonecrosis.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Dry Socket; Female; Humans; Hypercementosis; Imidazoles; Injections, Intravenous; Maxillary Diseases; Osteitis Deformans; Osteonecrosis; Pamidronate; Skull; Tooth Extraction; Tooth Socket; Zoledronic Acid | 2009 |
Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Topics: Adult; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Connective Tissue; Diphosphonates; Female; Humans; Imidazoles; Inflammation; Jaw; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Microscopy, Electron, Scanning; Middle Aged; Osteomyelitis; Osteonecrosis; Osteoporosis; Osteoradionecrosis; Pamidronate; Time Factors; Zoledronic Acid | 2010 |
[Maxillary osteonecrosis associated with the use of zoledronate: Presentation of three cases].
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Male; Maxillary Diseases; Middle Aged; Osteonecrosis; Zoledronic Acid | 2010 |
Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Maxillary Diseases; Multiple Myeloma; Oroantral Fistula; Osteonecrosis; Zoledronic Acid | 2010 |
A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw.
Topics: Animals; Bone Density Conservation Agents; Diphosphonates; Disease Models, Animal; Female; Imidazoles; Injections, Intravenous; Jaw Diseases; Maxillary Diseases; Osteonecrosis; Radionuclide Imaging; Rats; Rats, Wistar; Reproducibility of Results; Tooth Extraction; Zoledronic Acid | 2010 |
Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.
Topics: Adult; Aged; Alendronate; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphosphonates; Dry Socket; Female; Humans; Imaging, Three-Dimensional; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Oroantral Fistula; Osteonecrosis; Osteosclerosis; Pamidronate; Radiography, Dental, Digital; Radiography, Panoramic; Tooth Socket; Zoledronic Acid | 2010 |
Management of osteonecrosis of the jaws in patients with history of bisphosphonates therapy.
Topics: Absorbable Implants; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Cephalexin; Combined Modality Therapy; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Hyperbaric Oxygenation; Imidazoles; Maxillary Diseases; Membranes, Artificial; Osteonecrosis; Osteosclerosis; Patient Care Team; Platelet-Rich Plasma; Treatment Outcome; Wound Healing; Zoledronic Acid | 2010 |
Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.
Topics: Age Factors; Alveolar Process; Animals; Bicuspid; Bone Density Conservation Agents; Bone Remodeling; Dental Implantation, Endosseous; Diphosphonates; Dogs; Femur; Fluoresceins; Fluorescent Dyes; Imidazoles; L-Lactate Dehydrogenase; Male; Mandible; Mandibular Diseases; Maxilla; Maxillary Diseases; Models, Animal; Orthodontic Anchorage Procedures; Osteogenesis; Osteonecrosis; Random Allocation; Ribs; Tooth Extraction; Wound Healing; Zoledronic Acid | 2011 |
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bone Density Conservation Agents; Carcinoma; Chronic Disease; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Maxillary Sinusitis; Middle Aged; Osteonecrosis; Osteoporosis; Osteotomy; Recurrence; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2011 |
Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Topics: Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Mandibular Diseases; Maxillary Diseases; Middle Aged; Osteoporosis, Postmenopausal; Risedronic Acid; Tooth Extraction; Tooth Socket; Zoledronic Acid | 2012 |
Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Male; Maxillary Diseases; Maxillary Sinusitis; Oroantral Fistula; Pamidronate; Radiography, Panoramic; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid | 2012 |
Comparison of effects of clodronate and zoledronic acid on the repair of maxilla surgical wounds - histomorphometric, receptor activator of nuclear factor-kB ligand, osteoprotegerin, von Willebrand factor, and caspase-3 evaluation.
Topics: Animals; Bacterial Load; Bone Density Conservation Agents; Caspase 3; Clodronic Acid; Connective Tissue; Diphosphonates; Epithelium; Female; Imidazoles; Maxilla; Maxillary Diseases; Mouth Mucosa; Osteonecrosis; Osteoprotegerin; RANK Ligand; Rats; Rats, Wistar; Tooth Extraction; Tooth Socket; von Willebrand Factor; Wound Healing; Zoledronic Acid | 2012 |
Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Collagen Type I; Diphosphonates; Female; Humans; Imidazoles; Maxillary Diseases; Maxillary Osteotomy; Middle Aged; Multiple Myeloma; Pamidronate; Peptides; Surgical Flaps; Tooth Extraction; Zoledronic Acid | 2012 |
Bisphosphonates-related osteonecrosis of the jaws: a preliminary study of salivary interleukins.
Topics: Biomarkers; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Injections, Intravenous; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-1alpha; Interleukin-1beta; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Proteome; Saliva; Salivary Proteins and Peptides; Zoledronic Acid | 2013 |
Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
Topics: Aged; Bone Density Conservation Agents; Debridement; Diphosphonates; Female; Humans; Imidazoles; Maxillary Diseases; Osteonecrosis; Tooth Extraction; Zoledronic Acid | 2005 |
Special precautions.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Diphosphonates; Fatal Outcome; Female; Humans; Imidazoles; Maxillary Diseases; Osteonecrosis; Zoledronic Acid | 2005 |
Bisphosphonates, cancer, and osteonecrosis--a single practice experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Debridement; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Neoplasms; Osteonecrosis; Pamidronate; Zoledronic Acid | 2005 |
Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Topics: Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Bone Neoplasms; Curettage; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Recurrence; Zoledronic Acid | 2005 |
Does avascular necrosis of the jaws in cancer patients only occur following treatment with bisphosphonates?
Topics: Adult; Aged; Bone Density Conservation Agents; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Mandibular Diseases; Maxillary Diseases; Multiple Myeloma; Osteomyelitis; Osteonecrosis; Zoledronic Acid | 2005 |
[Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].
Topics: Aged; Alendronate; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Mouth Diseases; Osteonecrosis; Osteoporosis, Postmenopausal; Pamidronate; Plasmacytoma; Radiography, Panoramic; Risk Factors; Zoledronic Acid | 2005 |
Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Topics: Adenocarcinoma; Aged, 80 and over; Bone Density Conservation Agents; Carcinoma; Diabetes Mellitus, Type 2; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Patient Care Planning; Tooth Extraction; Zoledronic Acid | 2006 |
Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
Topics: Adult; Aged; Biopsy; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Follow-Up Studies; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Injections, Intravenous; Jaw Diseases; Magnetic Resonance Imaging; Male; Mandible; Mandibular Diseases; Maxilla; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Pamidronate; Radiography, Panoramic; Radionuclide Imaging; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid | 2006 |
Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.
Topics: Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antifungal Agents; Bone Density Conservation Agents; Bone Neoplasms; Chlorhexidine; Curettage; Diphosphonates; Female; Humans; Hydrogen Peroxide; Imidazoles; Jaw Diseases; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Mouthwashes; Multiple Myeloma; Osteonecrosis; Osteoporosis; Pamidronate; Radiography; Time Factors; Zoledronic Acid | 2006 |
Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
Topics: Aged; Aged, 80 and over; Alveolar Process; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Mandibular Diseases; Maxillary Diseases; Middle Aged; Multiple Myeloma; Osteonecrosis; Radiography; Severity of Illness Index; Zoledronic Acid | 2007 |
Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Humans; Imidazoles; Injections, Intravenous; Male; Maxillary Diseases; Osteitis Deformans; Osteonecrosis; Pamidronate; Zoledronic Acid | 2008 |